C. Pasquazzi

952 total citations
18 papers, 422 citations indexed

About

C. Pasquazzi is a scholar working on Hepatology, Epidemiology and Immunology. According to data from OpenAlex, C. Pasquazzi has authored 18 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Hepatology, 12 papers in Epidemiology and 4 papers in Immunology. Recurrent topics in C. Pasquazzi's work include Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (7 papers). C. Pasquazzi is often cited by papers focused on Hepatitis C virus research (14 papers), Liver Disease Diagnosis and Treatment (10 papers) and Hepatitis B Virus Studies (7 papers). C. Pasquazzi collaborates with scholars based in Italy. C. Pasquazzi's co-authors include Antonio Aceti, Barbara Zechini, C. De Bac, Gloria Taliani, A. Bozza, Pierfranco Terrosu, Caterina Furlan, Luca Messerini, Tommaso Stroffolini and Vieri Boddi and has published in prestigious journals such as Gastroenterology, Hepatology and Journal of Hepatology.

In The Last Decade

C. Pasquazzi

18 papers receiving 394 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Pasquazzi Italy 10 303 284 99 43 37 18 422
Stanislas Pol France 7 436 1.4× 488 1.7× 107 1.1× 92 2.1× 49 1.3× 7 645
C. De Bac Italy 11 424 1.4× 421 1.5× 108 1.1× 17 0.4× 18 0.5× 27 542
C. Vandelli Italy 10 525 1.7× 513 1.8× 92 0.9× 93 2.2× 46 1.2× 26 674
Sousuke Terazawa Japan 5 538 1.8× 528 1.9× 75 0.8× 21 0.5× 21 0.6× 5 626
H. Zylberberg France 10 436 1.4× 391 1.4× 141 1.4× 14 0.3× 40 1.1× 32 571
Pierre Berthelot France 9 250 0.8× 272 1.0× 60 0.6× 15 0.3× 49 1.3× 10 447
P Amoroso Italy 12 467 1.5× 364 1.3× 139 1.4× 29 0.7× 196 5.3× 21 658
María Sales Gilabert Spain 2 534 1.8× 476 1.7× 189 1.9× 22 0.5× 18 0.5× 5 624
Ana Arizcorreta Spain 7 382 1.3× 316 1.1× 108 1.1× 26 0.6× 12 0.3× 12 428
Blaine Hollinger United States 12 487 1.6× 506 1.8× 56 0.6× 36 0.8× 27 0.7× 17 626

Countries citing papers authored by C. Pasquazzi

Since Specialization
Citations

This map shows the geographic impact of C. Pasquazzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Pasquazzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Pasquazzi more than expected).

Fields of papers citing papers by C. Pasquazzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Pasquazzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Pasquazzi. The network helps show where C. Pasquazzi may publish in the future.

Co-authorship network of co-authors of C. Pasquazzi

This figure shows the co-authorship network connecting the top 25 collaborators of C. Pasquazzi. A scholar is included among the top collaborators of C. Pasquazzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Pasquazzi. C. Pasquazzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Ponziani, Francesca Romana, Massimo Siciliano, Raffaella Lionetti, et al.. (2017). Effectiveness of Paritaprevir/Ritonavir/Ombitasvir/Dasabuvir in Hemodialysis Patients With Hepatitis C Virus Infection and Advanced Liver Fibrosis: Case Reports. American Journal of Kidney Diseases. 70(2). 297–300. 14 indexed citations
2.
Ponziani, Francesca Romana, Raffaella Lionetti, C. Pasquazzi, et al.. (2017). Effectiveness of HCV antiviral treatment in patients with cirrhosis or advanced fibrosis and end-stage kidney disease on dialysis. Digestive and Liver Disease. 49(1). e24–e25. 1 indexed citations
3.
Ponziani, Francesca Romana, Massimo Siciliano, Raffaella Lionetti, et al.. (2017). P.09.4: Effectiveness of HCV Antiviral Treatment in Patients with Cirrhosis or Advanced Fibrosis and end-Stage Kidney Disease on Dialysis. Digestive and Liver Disease. 49. e188–e189. 1 indexed citations
4.
Taliani, Gloria, Carlo Ferrari, Antonio Aceti, et al.. (2006). Pegylated Interferon Alfa-2b Plus Ribavirin in the Retreatment of Interferon-Ribavirin Nonresponder Patients. Gastroenterology. 130(4). 1098–1106. 65 indexed citations
5.
Aceti, Antonio, Maria Luisa Mangoni, C. Pasquazzi, et al.. (2006). α‐Defensin increase in peripheral blood mononuclear cells from patients with hepatitis C virus chronic infection. Journal of Viral Hepatitis. 13(12). 821–827. 18 indexed citations
7.
Aceti, Antonio, et al.. (2005). Development of hepatotoxicity in HIV patients switching at least one protease inhibitor. International Journal of STD & AIDS. 16(2). 148–152. 4 indexed citations
8.
Zechini, Barbara, Antonella Teggi, Manila Antonelli, et al.. (2004). A case report of pityriasis lichenoides in a patient with chronic hepatitis C. Journal of Infection. 51(2). E23–E25. 5 indexed citations
9.
Aceti, Antonio, et al.. (2004). Helicobacter pylori active infection in patients with acute coronary heart disease. Journal of Infection. 49(1). 8–12. 32 indexed citations
10.
Zechini, Barbara, C. Pasquazzi, & Antonio Aceti. (2004). Correlation of serum aminotransferases with HCV RNA levels and histological findings in patients with chronic hepatitis C. European Journal of Gastroenterology & Hepatology. 16(9). 891–896. 53 indexed citations
11.
Frasca, Loredana, Cristiano Scottà, Paola Del Porto, et al.. (2003). Antibody–Selected Mimics of Hepatitis C Virus Hypervariable Region 1 Activate Both Primary and Memory Th Lymphocytes. Hepatology. 38(3). 653–663. 10 indexed citations
12.
Taliani, Gloria, Gerardo Nigro, Mara Biasin, et al.. (2002). Serum Concentration of γGT Is a Surrogate Marker of Hepatic TNF-α mRNA Expression in Chronic Hepatitis C. Clinical Immunology. 105(3). 279–285. 18 indexed citations
13.
Aceti, Antonio, C. Pasquazzi, Barbara Zechini, & C. De Bac. (2002). Hepatotoxicity Development During Antiretroviral Therapy Containing Protease Inhibitors in Patients With HIV. JAIDS Journal of Acquired Immune Deficiency Syndromes. 29(1). 41–48. 128 indexed citations
14.
Gaeta, G.B., Maria Stanzione, Tiziana Ascione, et al.. (2001). Interferon‐α plus amantadine in chronic hepatitis C resistant to interferon alone: a pilot randomized study. Journal of Viral Hepatitis. 8(4). 284–286. 15 indexed citations
15.
Taliani, Gloria, C. Pasquazzi, Vieri Boddi, et al.. (2000). Early HCV-RNA clearance during daily administration of interferon in combination with ribavirin in naive HCV patients. Journal of Hepatology. 32. 179–179. 4 indexed citations
16.
Bac, C. De, A. Bozza, C. Pasquazzi, et al.. (1997). Liver cirrhosis: Epidemiological aspects in Italy. Research in Virology. 148(2). 139–142. 5 indexed citations
17.
Taliani, Gloria, et al.. (1997). HCV infection of peripheral blood mono nuclear cells and serum levels of soluble ICAM-1 in patients treated with interferon. Archives of Virology. 142(3). 557–565. 3 indexed citations
18.
Taliani, Gloria, et al.. (1995). Hepatitis C virus RNA in peripheral blood mononuclear cells: Relation with response to interferon treatment. Journal of Medical Virology. 47(1). 16–22. 40 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026